2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 CAS 63950-06-1

Purity 97%+In StockPharmaceutical Standards
CAS No.63950-06-1
Molecular FormulaC27H29NO10
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

2UB1JJT82D
63950-06-1
Esorubicin hydrochloride [USAN]
(2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))-
(8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
4'-Deoxydoxorubicin hydrochloride
EINECS 264-575-1
NSC 267469
Esorubicin HCl
UNII-2UB1JJT82D
Esorubicin hydrochloride
IMI 58 CAS 63950-06-1 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58.

CATO supplies 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 (CAS 63950-06-1), a certified reference material (molecular formula C27H29NO10HCl, MW 563.98 g/mol) for analytical method development and quality control.

Based on its molecular formula C27H29NO10HCl, 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 563.98 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

As a certified reference material (CRM), 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC27H29NO10 HCl
Molecular Weight563.98 g/mol
AppearancePale yellow to yellow crystalline powder. (slight halide-like odor)
Purity97%+
StorageStore at room temperature, protect from light, keep sealed and dry
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)13.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1975
Halogen ContentCl-containing
Nitrogen Atoms1

Recommended Standards

Why CATO?